Based on the Elanco Animal Health stock forecast from 7 analysts, the average analyst target price for Elanco Animal Health is USD 16.08 over the next 12 months. Elanco Animal Health’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Elanco Animal Health is Neutral, which is based on 6 positive signals and 7 negative signals. At the last closing, Elanco Animal Health’s stock price was USD 8.62. Elanco Animal Health’s stock price has changed by -5.79% over the past week, -14.14% over the past month and -41.56% over the last year.
No recent analyst target price found for Elanco Animal Health
No recent average analyst rating found for Elanco Animal Health
Company Overview Elanco Animal Health
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. Read Less
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and inte...Read More
Frequently Asked Questions About Elanco Animal Health (ELAN) Stock
Based on ratings from 7 analysts Elanco Animal Health's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and 6 hold ratings.
Unfortunately we do not have enough data on ELAN's stock to indicate if its a good dividend stock.
Based on targets from 7 analysts, the average taret price for ELAN is USD 16.08 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 12.
ELAN stock's Price/Earning ratio is 16.38.
Our analysis grades ELAN stock's Price / Earning ratio at B+. This means that ELAN stock's Price/Earning ratio is above 12% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this ELAN may be undervalued for its sector.
The last closing price of ELAN's stock was USD 8.62.
The most recent market capitalization for ELAN is USD 5.51B.
Based on targets from 7 analysts, the average taret price for ELAN is projected at USD 16.08 over the next 12 months.
This means that ELAN's stock price may go up by +86.51% over the next 12 months.
We can't find any ETFs which contains Elanco Animal Health's stock.
As per our most recent records Elanco Animal Health has 9,000 Employees.
Elanco Animal Health's registered address is 2500 Innovation Way, Greenfield, IN, United States, 46140.
You can get more information about it from Elanco Animal Health's website at https://www.elanco.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Elanco Animal Health (ELAN) Stock
Based on ratings from 7 analysts Elanco Animal Health's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and 6 hold ratings.
Unfortunately we do not have enough data on ELAN's stock to indicate if its a good dividend stock.
Based on targets from 7 analysts, the average taret price for ELAN is USD 16.08 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 12.
ELAN stock's Price/Earning ratio is 16.38.
Our analysis grades ELAN stock's Price / Earning ratio at B+. This means that ELAN stock's Price/Earning ratio is above 12% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange.
Based on this ELAN may be undervalued for its sector.
The last closing price of ELAN's stock was USD 8.62.
The most recent market capitalization for ELAN is USD 5.51B.
Based on targets from 7 analysts, the average taret price for ELAN is projected at USD 16.08 over the next 12 months.
This means that ELAN's stock price may go up by +86.51% over the next 12 months.
We can't find any ETFs which contains Elanco Animal Health's stock.
As per our most recent records Elanco Animal Health has 9,000 Employees.
Elanco Animal Health's registered address is 2500 Innovation Way, Greenfield, IN, United States, 46140.
You can get more information about it from Elanco Animal Health's website at https://www.elanco.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ELAN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
